Guillo; Nathalie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guillo; Nathalie.The latest application filed is for "immunogenic compositions against s. aureus".

Company Profile

1.12.11

Guillo; Nathalie - Paris FR
Guillo; Nathalie - Toulouse FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunogenic compositions against S. aureus Grant 10,772,946 - Driguez , et al. Sept	2020-09-15
Immunogenic Compositions Against S. Aureus App 20180280491 - DRIGUEZ; Pierre-Alexandre ; et al.	2018-10-04
Pyrazolonaphthyridinone derivatives as MetAP2 inhibitors (methionine aminopeptidase type-2) Grant 9,856,257 - Guillo , et al. January 2, 2	2018-01-02
Pyrazolonaphthyridinone Derivatives As Metap2 Inhibitors (methionine Aminopeptidase Type-2) App 20160060265 - GUILLO; Nathalie ; et al.	2016-03-03
Substituted dimeric quinazoline-2,4-diones as FGF receptor agonists Grant 9,206,177 - Benazet , et al. December 8, 2	2015-12-08
Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof Grant 9,169,246 - Benazet , et al. October 27, 2	2015-10-27
FGF-receptor agonist dimeric compounds Grant 9,120,819 - Bono , et al. September 1, 2	2015-09-01
FGF receptor (FGFR) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof Grant 9,034,898 - Clary-Ceccato , et al. May 19, 2	2015-05-19
FGF Receptor (FGFR) Agonist Dimeric Compounds, Process for the Preparation Thereof and Therapeutic Use Thereof App 20150011579 - Clary-Ceccato; Marie-Line ; et al.	2015-01-08
FGF Receptor (FGFR) Agonist Dimeric Compounds, Process for the Preparation Thereof and Therapeutic Use Thereof App 20140378483 - Benazet; Alexandre ; et al.	2014-12-25
Pyrazoloquinolinone Derivatives, Preparation Thereof And Therapeutic Use Thereof App 20130079337 - BENAZET; ALEXANDRE ; et al.	2013-03-28
Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis Grant 8,034,828 - Badorc , et al. October 11, 2	2011-10-11
1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for preparing them and pharmaceutical compositions containing them Grant 7,803,811 - Badorc , et al. September 28, 2	2010-09-28
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives Grant 7,553,845 - Alcouffe , et al. June 30, 2	2009-06-30
Fgf-receptor Agonist Dimeric Compounds App 20090069368 - BONO; Francoise ; et al.	2009-03-12
Use Of Fgf Inhibiting Substituted 1,2,3 Indolizine Derivatives In The Preparation Of Medicaments Which Can Be Used To Treat Diseases Linked To Pathological Choroidal Angiogenesis App 20090030034 - BADORC; Alain ; et al.	2009-01-29
Novel 1,2,3-Substituted Indolizine Derivatives, Inhibitors of FGFs, Method for Preparing Them and Pharmaceutical Compositions Containing Them App 20090023770 - BADORC; Alain ; et al.	2009-01-22
1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same Grant 7,442,708 - Badorc , et al. October 28, 2	2008-10-28
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives App 20060199962 - Alcouffe; Chantal ; et al.	2006-09-07
Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same App 20050203126 - Badorc, Alain ; et al.	2005-09-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.